NMN Side Effects: What the Research Shows

The Longevity Series · Safety

NMN Side Effects & Safety

What the published human NMN trials recorded on tolerability — and, just as important, what they were too small and too short to tell you. Who should take professional advice first, and why product quality is part of the safety question. For the wider set of safety, interaction and timing questions, see NMN questions answered.

4 human trials described25–80 participants each4–12 weeks duration0 authorised health claimsUpdated 5 Oct 2026
Quick answer

Short trials, stated limits.

In the published human NMN trials, no serious adverse events were reported. Those trials were small (25 to 80 people), short (four to twelve weeks) and mostly in healthy adults, so they cannot tell you whether NMN is safe for you, or over the long term.

What trials recorded
No serious adverse events reportedIn four small trials at 250–1250mg/day
What they cannot show
Long-term or individual safetyNo multi-year human data; small numbers; mostly healthy volunteers
Highest dose studied
1250mg/day for 4 weeksA safety study in 31 healthy adults (Fukamizu 2022)
Ask first if
Pregnant, breastfeeding, on medication or managing a conditionNot for under-18s
Product quality
Part of the safety pictureVerified purity and independent batch testing. How to choose
UK regulatory status — read this first

NMN is widely sold in the UK but its position is not settled: a GB novel food application for β-NMN (FSA reference RP-2116) is under assessment by the Food Standards Agency, and EFSA published a positive safety opinion in the EU in 2026 with formal authorisation still pending. Neither is a UK authorisation. No authorised UK or EU health claim exists for NMN.

What the studies were

The human trials, by design.

These are the published human NMN trials we reference. We describe their design only and do not summarise their outcomes. On tolerability, the neutral statement is this: no serious adverse events were reported in these short trials. That is not proof of safety, and it does not extend beyond the populations, doses and durations shown. For what NMN is, see what is NMN? and what is NAD+?

Study Population n Daily dose Duration
Yoshino et al., Science 2021 Postmenopausal women with prediabetes; placebo-controlled 25 250mg 10 weeks
Igarashi et al., npj Aging 2022 Healthy older men 42 250mg 12 weeks
Yi et al., GeroScience 2023 Healthy middle-aged adults; dose-ranging 80 300 / 600 / 900mg 60 days
Fukamizu et al., Sci Rep 2022 Healthy adults; safety study 31 1250mg 4 weeks

Efficacy-trial range 250–900mg/day; one safety study at 1250mg/day. More: NMN clinical trials · NMN dosage

If something happens

Effects people ask about.

The published trials were too small to say how common any particular effect is, so we do not attach frequencies. The effects people most often ask about are digestive discomfort, nausea, headache and a feeling of warmth or flushing.

NMN is not niacin, so the classic high-dose “niacin flush” is not something to expect from it — but any supplement can disagree with an individual. Take it as the label directs (our capsules: two daily with water, preferably with food) and do not exceed the stated dose.

Stop taking it and speak to a pharmacist or GP if you experience anything unexpected, or any allergic-type reaction. In an emergency call 999.

Take professional advice first

Who should be cautious.

NMN is a food supplement, not a medicine, and it has not been studied in every group. If any of these apply to you, talk to a qualified healthcare professional before starting.

Pregnancy
Pregnant or breastfeedingNot studied in these groups — not recommended
Medication
Taking prescription medicinesNo robust interaction data — ask your doctor or pharmacist. Specific medicines: NMN questions
Conditions
Managing a medical conditionIncluding liver, kidney or metabolic conditions, or a history of cancer
Age
Under 18Not suitable for children
Surgery
Due to have an operationTell your clinician about every supplement you take
Safety starts with the product

Why quality is a safety issue.

The trials describe the NMN that was tested in them, not every product on sale. A product with unverified purity may contain manufacturing by-products or contaminants, or less NMN than the label states. That is why quality belongs in a safety guide.

Look for purity stated as β-NMN, every finished batch tested by an independent ISO/IEC 17025-accredited laboratory, heavy-metal and microbiological testing, a batch number on the pack, and full dose disclosure with no proprietary blend. The full checklist is in how to choose an NMN supplement, and how to spot genuine NMN covers authenticity. Every Vitality batch is tested by an ISO/IEC 17025-accredited laboratory and our products are UK manufactured — details on quality & testing.

Next step

Know the dose you’re choosing.

Every Vitality NMN formula side by side, with where each dose sits against the trials above. We make and sell them; it is a comparison, not a ranking.

FAQs

NMN safety FAQ.

The published human trials gave NMN daily for four to twelve weeks, to small groups of mostly healthy adults, and no serious adverse events were reported in them. They do not tell you about daily use over months or years, or about people with medical conditions. Take it only as your label directs, and speak to a healthcare professional first if you take medication or have a health condition.
The published trials were too small to establish how common any particular effect is. The effects people ask about most are digestive discomfort, nausea, headache and a feeling of warmth or flushing. If you notice anything unexpected, stop taking it and speak to a pharmacist or GP.
Some of the short trials included routine blood safety markers, but they enrolled small numbers of mostly healthy adults for a few weeks. People with liver, kidney or other medical conditions were not represented in a way that answers this question, so if that applies to you, speak to a qualified healthcare professional before using NMN.
There is no robust research on NMN and drug interactions. Anyone taking prescription medication should discuss NMN with their doctor or pharmacist before starting.
Do not exceed the recommended daily dose on your label. For context, the published efficacy trials used 250–900mg per day and the highest dose in a published human safety study was 1250mg per day for four weeks; nothing is known about amounts above that. If you have taken more than directed and feel unwell, contact NHS 111 or a pharmacist.
The trials describe the NMN they tested, not every product on the market. A product with unverified purity may contain by-products or contaminants, or less NMN than the label states. Look for purity stated as β-NMN, every finished batch tested by an independent ISO/IEC 17025-accredited laboratory, heavy-metal and microbiological testing, and a batch number on the pack. Our how to choose an NMN supplement guide sets out the full checklist.
Primary sources

References & sources.

These studies concern nicotinamide mononucleotide as investigated in research, not any Vitality product. They are cited for their design; we do not summarise outcomes. Full citations are on our research references page.

Citation DOI
Yoshino M, Yoshino J, Kayser BD, et al. Science, 2021 10.1126/science.abe9985
Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. npj Aging, 2022 10.1038/s41514-022-00084-z
Yi L, Maier AB, Tao R, et al. GeroScience, 2023 10.1007/s11357-022-00705-1
Fukamizu Y, Uchida Y, Shigekawa A, et al. Scientific Reports, 2022 10.1038/s41598-022-18272-y
Further reading

Keep going.

About this guide

Last reviewed 5 October 2026 by the Vitality Supplements Editorial Team, written to our editorial standards. We make and sell NMN products. Trials are described by design only. First published 7 June 2026; rebuilt 5 October 2026 with the UK regulatory status, a trial-design table including the 1250mg safety study, and neutral tolerability wording that states the trials’ limits.

Food supplements should not be used as a substitute for a varied, balanced diet and a healthy lifestyle. Do not exceed the stated recommended daily dose. NMN is not yet an authorised novel food in Great Britain (application RP-2116 under assessment). No authorised UK or EU health claims exist for any ingredient on this page, and no medicinal, disease or anti-ageing claims are made. Not suitable for children. Consult a healthcare professional before use if pregnant, breastfeeding, taking medication or under medical supervision. General information, not medical advice. See our disclaimer · Contact